论文部分内容阅读
目的为探讨抗原125(CA125)、癌胚抗原(CEA)联合测定在卵巢癌诊断中的价值。方法分别同时测定正常妇女48例、卵巢良性肿瘤患者15例和64例卵巢癌患者的血清CA125、CEA水平。结果卵巢癌患者CA125、CEA阳性率分别为70.3%、54.5%,联合测定阳性率为85.9%。结论CA125、CEA同时进行检测可提高卵巢癌的阳性诊断率,能达到早期诊断的目的。
Objective To investigate the value of combined detection of antigen 125 (CA125) and carcinoembryonic antigen (CEA) in the diagnosis of ovarian cancer. Methods Serum levels of CA125 and CEA in 48 women with normal ovarian tumors, 15 with ovarian benign tumors and 64 with ovarian cancer were measured simultaneously. Results The positive rates of CA125 and CEA in ovarian cancer patients were 70.3% and 54.5%, respectively. The positive rate of combined detection was 85.9%. Conclusions Simultaneous detection of CA125 and CEA can improve the positive diagnosis rate of ovarian cancer and achieve the purpose of early diagnosis.